Calton & Associates’s Express Scripts Holding Company ESRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ESRX
ECM
BJL
BSPF
MYAM
AWM
W
ACA
UCFA
SBL
Calton & Associates's ESRX Position: Q4 2018 in Review
Calton & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,178 shares — an estimated $207K sold.
Calton & Associates first reported a position in ESRX in Q4 2017 and held it in 3 quarters. The position peaked at $235K in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.
- Calton & Associates reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
- Calton & Associates sold 2,178 Express Scripts Holding Company shares in Q4 2018, an estimated $207K.
- Calton & Associates first reported a position in Express Scripts Holding Company in Q4 2017 and held it in 3 quarters.
- Calton & Associates's Express Scripts Holding Company position peaked at $235K in Q4 2017.
- 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.
Based on Calton & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.